Dr. Reddy's Laboratories Ltd (
) will begin trading ex-dividend on August 01, 2014. A cash
dividend payment of $0.303381 per share. Shareholders who purchased
RDY stock prior to the ex-dividend date are eligible for the cash
dividend payment. This represents an 14.75% increase over the prior
The previous trading day's last sale of RDY was $46.64,
representing a -2.69% decrease from the 52 week high of $47.93 and
a 48.91% increase over the 52 week low of $31.32.
RDY is a part of the Health Care sector, which includes
companies such as Johnson & Johnson (
) and Novartis AG (
). RDY's current earnings per share, an indicator of a company's
profitability, is $2.25. Zacks Investment Research reports RDY's
forecasted earnings growth in 2015 as 10.98%, compared to an
industry average of 9.5%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to RDY through an Exchange
Traded Fund [ETF]?
The following ETF(s) have RDY as a top-10 holding:
- EGShares Health Care GEMS Exchange Traded Fund (HGEM)
- First Trust ISE Chindia Index Fund (
- First Trust BICK Index Fund (
- iShares MSCI Asia ex Japan Minimum Volatility ETF (
The top-performing ETF of this group is BICK with an increase of
16.37% over the last 100 days. HGEM has the highest percent
weighting of RDY at 4.65%.